Chimeric spike mRNA vaccines protect against Sarbecoviru
SARS-CoV-2
SARS-like virus
Sarbecovirus
mRNA vaccine
universal coronavirus vaccine
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
11 May 2021
11 May 2021
Historique:
pubmed:
25
3
2021
medline:
25
3
2021
entrez:
24
3
2021
Statut:
epublish
Résumé
The emergence of SARS-CoV in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination strategies against the broader
Identifiants
pubmed: 33758837
doi: 10.1101/2021.03.11.434872
pmc: PMC7986996
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Competing interests: The University of North Carolina at Chapel Hill has filed provisional patents for which D.R.M. and R.S.B are co-inventors (U.S. Provisional Application No. 63/106,247 filed on October 27th, 2020) for the chimeric vaccine constructs and their applications described in this study.
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Biochem Biophys Res Commun. 2005 Jul 22;333(1):186-93
pubmed: 15939399
Cell. 2020 Nov 12;183(4):1070-1085.e12
pubmed: 33031744
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9
pubmed: 19036930
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26915-26925
pubmed: 33046644
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
PLoS Pathog. 2018 Jan 2;14(1):e1006810
pubmed: 29293660
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Cell. 2021 Apr 29;184(9):2316-2331.e15
pubmed: 33773105
Science. 2021 Feb 12;371(6530):735-741
pubmed: 33436524
Nature. 2018 Apr;556(7700):255-258
pubmed: 29618817
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
PLoS Pathog. 2017 Nov 30;13(11):e1006698
pubmed: 29190287
J Virol. 2011 Dec;85(23):12201-15
pubmed: 21937658
Science. 2021 Feb 19;371(6531):759
pubmed: 33602830
Science. 2021 Feb 19;371(6531):823-829
pubmed: 33495307
Cell. 2020 Aug 6;182(3):722-733.e11
pubmed: 32645327
Immunity. 2020 Dec 15;53(6):1281-1295.e5
pubmed: 33296685
Pediatr Res. 2004 Jul;56(1):1-5
pubmed: 15152053
Immunity. 2020 Oct 13;53(4):724-732.e7
pubmed: 32783919
J Virol. 1988 Jun;62(6):1989-98
pubmed: 2835504
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
pubmed: 26976607
Virology. 1990 Apr;175(2):548-55
pubmed: 2158184
Science. 2021 Jun 4;372(6546):1108-1112
pubmed: 33947773
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
PLoS Pathog. 2007 Jan;3(1):e5
pubmed: 17222058
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Mol Ther. 2020 Jul 8;28(7):1569-1584
pubmed: 32359470
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
N Engl J Med. 2021 Mar 17;384(15):1468-1470
pubmed: 33730471
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279